To examine the impact of chronic comorbidities on mortality in Acute Respiratory Distress Syndrome (ARDS).
Materials and Methods
Retrospective cohort study of adults with ARDS (ICD-10-CM code J80) from the National Inpatient Sample between January, 2016 and December, 2018. For the primary outcome of mortality, we conducted weighted logistic regression adjusting for factors identified on univariate analysis as potentially significant or differing between the two groups at baseline. We used negative binomial regression adjusting for the same comorbidities to identify risk factors for longer length of stay (LOS) among ARDS survivors.
Results
After exclusions, 1046 records were analyzed (3355 ARDS survivors and 1875 non-survivors.) The comorbidities examined included hypertension, diabetes mellitus, obesity, hypothyroidism, alcohol and drug use, chronic kidney disease (CKD), cardiovascular disease, chronic liver disease, chronic pulmonary disease and malignancy. In multivariate analysis, we found that malignancy (OR 2.26, 95% CI 1.84-2.78, p < 0.001), cardiovascular disease (OR 1.54, 95% CI 1.23-1.92, p < 0.001), and CKD (OR 1.75, 95% CI 1.22-2.50, p = 0.002) increased the risk of death. In interaction analyses, cardiovascular disease combined with either malignancy or CKD conferred higher odds of death compared to either risk factor alone.
Conclusions
The comorbidity of malignancy confers the most reliable risk of poor outcomes in ARDS with higher odds of hospital death and a simultaneous association with longer hospital LOS among survivors.
BellaniGLaffeyJGPhamT, et al.Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315(8):788‐800.
MonchiMBellenfantFCariouA,et al.Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis. Am J Respir Crit Care Med. 1998;158(4):1076‐1081.
4.
NucktonTJAlonsoJAKalletRH,et al.Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome. N Engl J Med. 2002;346(17):1281‐1286.
5.
DaiQWangSLiuRWangHZhengJYuK. Risk factors for outcomes of acute respiratory distress syndrome patients: a retrospective study. J Thorac Dis. 2019;11(3):673‐685.
6.
SeeleyEMcAuleyDFEisnerMMiletinMMatthayMAKalletRH. Predictors of mortality in acute lung injury during the era of lung protective ventilation. Thorax. 2008;63(11):994‐998.
7.
BrownLMCalfeeCSMatthayMABrowerRGThompsonBTCheckleyW, National Institutes of Health Acute Respiratory Distress Syndrome Network I. A simple classification model for hospital mortality in patients with acute lung injury managed with lung protective ventilation. Crit Care Med. 2011;39(12):2645‐2651.
8.
StapletonRDWangBMHudsonLDRubenfeldGDCaldwellESSteinbergKP. Causes and timing of death in patients with ARDS. Chest. 2005;128(2):525‐532.
9.
DoyleRLSzaflarskiNModinGWWiener-KronishJPMatthayMA. Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med. 1995;152(6 Pt 1):1818‐1824.
10.
ZilberbergMDEpsteinSK. Acute lung injury in the medical ICU: comorbid conditions, age, etiology, and hospital outcome. Am J Respir Crit Care Med. 1998;157(4 Pt 1):1159‐1164.
11.
ZimmermanJEKramerAAKnausWA. Changes in hospital mortality for United States intensive care unit admissions from 1988 to 2012. Crit Care. 2013;17(2):R81.
12.
ZambonMVincentJL. Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest. 2008;133(5):1120‐1127.
13.
EricksonSEMartinGSDavisJLMatthayMAEisnerMDNetworkNNA. Recent trends in acute lung injury mortality: 1996–2005. Crit Care Med. 2009;37(5):1574‐1579.
14.
MacaJJorOHolubM,et al.Past and present ARDS mortality rates: a systematic review. Respir Care. 2017;62(1):113‐122.
15.
Acute Respiratory Distress Syndrome Network, BrowerRGMatthayMAMorrisASchoenfeldDThompsonBTWheelerA. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301‐1308.
16.
CookeCRKahnJMCaldwellE,et al.Predictors of hospital mortality in a population-based cohort of patients with acute lung injury. Crit Care Med. 2008;36(5):1412‐1420.
17.
AzoulayELemialeVMourvillierB, et al.Management and outcomes of acute respiratory distress syndrome patients with and without comorbid conditions. Intensive Care Med. 2018;44(7):1050‐1060.
18.
DarmonMClec'hCAdrieC, et al.Acute respiratory distress syndrome and risk of AKI among critically ill patients. Clin J Am Soc Nephrol. 2014;9(8):1347‐1353.
19.
LiuKDGliddenDVEisnerMD, et al.Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury. Crit Care Med. 2007;35(12):2755‐2761.
20.
PanitchoteAMehkriOHastingsA, et al.Factors associated with acute kidney injury in acute respiratory distress syndrome. Ann Intensive Care. 2019;9(1):74.
21.
WangCYCalfeeCSPaulDW, et al.One-year mortality and predictors of death among hospital survivors of acute respiratory distress syndrome. Intensive Care Med. 2014;40(3):388‐396.
22.
Rimes-StigareCFrumentoPBottaiMMartenssonJMartlingCRBellM. Long-term mortality and risk factors for development of end-stage renal disease in critically ill patients with and without chronic kidney disease. Crit Care. 2015;19(383).
23.
LemeshowSTeresDKlarJAvruninJSGehlbachSHRapoportJ. Mortality probability models (MPM II) based on an international cohort of intensive care unit patients. JAMA. 1993;270(20):2478‐2486.
24.
ZimmermanJEKramerAAMcNairDSMalilaFM. Acute physiology and chronic health evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients. Crit Care Med. 2006;34(5):1297‐1310.
25.
KnausWAWagnerDPDraperEA, et al.The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100(6):1619‐1636.
26.
Husain-SyedFMcCulloughPABirkHW,et al.Cardio-Pulmonary-Renal interactions: a multidisciplinary approach. J Am Coll Cardiol. 2015;65(22):2433‐2448.
MurphyDMcCullochCELinF, et al.Trends in prevalence of chronic kidney disease in the United States. Ann Intern Med. 2016;165(7):473‐481.
29.
VartPPoweNRMcCullochCE,et al.Centers for Disease C, Prevention Chronic Kidney Disease Surveillance T. National trends in the prevalence of chronic kidney disease among racial/ethnic and socioeconomic Status groups, 1988–2016. JAMA Netw Open. 2020;3(7):e207932.
30.
GacouinALocufierMUhelF,et al.Liver cirrhosis is independently associated with 90-day mortality in ARDS patients. Shock. 2016;45(1):16‐21.
31.
BoenteRDSheikhABossletGTGhabrilMS. Outcomes of acute respiratory distress syndrome in mechanically ventilated patients with cirrhosis. Crit Care Explor. 2019;1(9):e0040.
32.
LevesqueESalibaFIchaiPSamuelD. Outcome of patients with cirrhosis requiring mechanical ventilation in ICU. J Hepatol. 2014;60(3):570‐578.
33.
GalboisATrompetteMLDasV, et al.Improvement in the prognosis of cirrhotic patients admitted to an intensive care unit, a retrospective study. Eur J Gastroenterol Hepatol. 2012;24(8):897‐904.
34.
SalibaFIchaiPLevesqueESamuelD. Cirrhotic patients in the ICU: prognostic markers and outcome. Curr Opin Crit Care. 2013;19(2):154‐160.
35.
MartinGSManninoDMEatonSMossM. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546‐1554.
36.
KaoKCHsiehMJLinSW, et al.Survival predictors in elderly patients with acute respiratory distress syndrome: a prospective observational cohort study. Sci Rep. 2018;8(1):13459.
37.
DavidsonTARubenfeldGDCaldwellESHudsonLDSteinbergKP. The effect of acute respiratory distress syndrome on long-term survival. Am J Respir Crit Care Med. 1999;160(6):1838‐1842.
38.
ZhiGXinWYingWGuohongXShuyingL. “Obesity Paradox” in acute respiratory distress syndrome: asystematic review and meta-analysis. PLoS One. 2016;11(9):e0163677.
39.
NiYNLuoJYuH,et al.Can body mass index predict clinical outcomes for patients with acute lung injury/acute respiratory distress syndrome? A meta-analysis. Crit Care. 2017;21(1):36.
40.
Prevention CfDCa. Hypertension Cascade: Hypertension Prevalence, Treatment and Control Estimates Among U.S. Adults Aged 18 Years and Older Applying the Criteria from the American College of Cardiology and American Heart Association’s 2017 Hypertension Guideline—NHANES 2015–2018. US Department of Health and Human Services; 2021.
41.
BustamanteAF. Adipose-lung cell crosstalk in the obesity-ARDS paradox. J Pulm Respir Med. 2013;3:44.
42.
TomiyamaHShiinaKMatsumoto-NakanoC, et al.The contribution of inflammation to the development of hypertension mediated by increased arterial stiffness. J Am Heart Assoc. 2017;6(7).
43.
DinhQNDrummondGRSobeyCGChrissobolisS. Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. Biomed Res Int. 2014;2014:406960.
44.
SolakYAfsarBVaziriND,et al.Hypertension as an autoimmune and inflammatory disease. Hypertens Res. 2016;39(8):567‐573.
45.
Clemente-MoragonAMartinez-MillaJOliverE, et al.Metoprolol in critically ill patients with COVID-19. J Am Coll Cardiol. 2021;78(10):1001‐1011.
46.
van der JagtMMirandaDR. Beta-blockers in intensive care medicine: potential benefit in acute brain injury and acute respiratory distress syndrome. Recent Pat Cardiovasc Drug Discov. 2012;7(2):141‐151.
47.
YanFHuangFXuJ, et al.Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients. Cell Discov. 2020;6(1):77.
48.
LopesRDMacedoAVSde BarrosESPGM, et al.Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: a randomized clinical trial. JAMA. 2021;325(3):254‐264.
49.
KaparianosAArgyropoulouE. Local renin-angiotensin II systems, angiotensin-converting enzyme and its homologue ACE2: their potential role in the pathogenesis of chronic obstructive pulmonary diseases, pulmonary hypertension and acute respiratory distress syndrome. Curr Med Chem. 2011;18(23):3506‐3515.
50.
LuoLShaverCMZhaoZ,et al.Clinical predictors of hospital mortality differ between direct and indirect ARDS. Chest. 2017;151(4):755‐763.
51.
EworukeEMajorJMGilbert McClainLI. National incidence rates for acute respiratory distress syndrome (ARDS) and ARDS cause-specific factors in the United States (2006–2014). J Crit Care. 2018;47:192‐197.
52.
LuhrORKarlssonMThorsteinssonARylanderCFrostellCG. The impact of respiratory variables on mortality in non-ARDS and ARDS patients requiring mechanical ventilation. Intensive Care Med. 2000;26(5):508‐517.
53.
GattinoniLCaironiPCressoniM, et al.Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med. 2006;354(17):1775‐1786.
54.
ParchaVKalraRBhattSPBerraLAroraGAroraP. Trends and geographic variation in acute respiratory failure and ARDS mortality in the United States. Chest. 2021;159(4):1460‐1472.
55.
CochiSEKempkerJAAnnangiSKramerMRMartinGS. Mortality trends of acute respiratory distress syndrome in the United States from 1999 to 2013. Ann Am Thorac Soc. 2016;13(10):1742‐1751.
56.
KershawKNDiez RouxAVCarnethonM,et al.Geographic variation in hypertension prevalence among blacks and whites: the multi-ethnic study of atherosclerosis. Am J Hypertens. 2010;23(1):46‐53.
57.
TannerRMGutierrezOMJuddS, et al.Geographic variation in CKD prevalence and ESRD incidence in the United States: results from the reasons for geographic and racial differences in stroke (REGARDS) study. Am J Kidney Dis. 2013;61(3):395‐403.
58.
JankowskiJFloegeJFliserDBohmMMarxN. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation. 2021;143(11):1157‐1172.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
